Yuanxiang Tao is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of neurology, holding a total of 6 patents. His work focuses on innovative methods and compositions for treating neuropathic pain, showcasing his dedication to advancing medical science.

Latest Patents

One of his latest patents addresses the treatment of neuropathic pain. This invention provides methods and compositions useful for alleviating this condition. Specifically, it includes a recombinant Kcna2 sense fragment, which plays a crucial role in the treatment process. Another notable patent involves the inhibition of the interaction between PSD93 and PSD95 with nNOS and NMDA receptors. This research indicates that PSD-95/SAP90 mediates the role of the NMDA receptor in determining the minimum alveolar concentration (MAC) of inhalational anesthetics. The suppression of PSD-95/SAP90 expression in the spinal cord significantly reduces responses to painful stimuli mediated through NMDA receptor activation.

Career Highlights

Yuanxiang Tao's career is marked by his innovative research and contributions to neurology. His work has not only advanced the understanding of neuropathic pain but has also provided new avenues for treatment. His dedication to research and development in this field has made him a respected figure among his peers.

Collaborations

Yuanxiang collaborates with Roger A Johns, further enhancing the impact of his research. Their combined expertise contributes to the advancement of neurological treatments and innovations.

Conclusion

Yuanxiang Tao's contributions to the field of neurology through his patents and research are invaluable. His innovative approaches to treating neuropathic pain demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com